JCRRF (JCR Pharmaceuticals Co) Beta: 0.2107 (As of Jun. 26, 2026)


JCRRF JCR Pharmaceuticals Co Ltd JCRRF
65 GF Score
Price $3.15
GF Value $4.97
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Beta?

JCR Pharmaceuticals Co JCRRF 65 Beta is 0.2107 as of Jun. 26, 2026. GuruFocus rates JCRRF with a GF Score™ of 65/100 and a GF Value™ of $4.97 (Possible Value Trap). The stock has 8 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), JCR Pharmaceuticals Co's Beta is 0.2107.


JCR Pharmaceuticals Co  (OTCPK:JCRRF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


JCR Pharmaceuticals Co Beta Related Terms


JCR Pharmaceuticals Co Beta Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co Beta Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.23 0.31 0.22

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.39 0.51 0.59 0.22

JCRRF vs LLY, JNJ, ABBV: Beta Comparison

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Beta distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Beta falls into.


JCRRF
65GF Score
JCR Pharmaceuticals Co Ltd JCRRF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.2107 mean?
JCR Pharmaceuticals Co (JCRRF) has a Beta of 0.2107 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's Beta too high?
JCR Pharmaceuticals Co's current Beta is 0.2107. Overall, JCR Pharmaceuticals Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Beta compare to LLY and JNJ?
JCR Pharmaceuticals Co's Beta of 0.2107 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current Beta is 0.2107. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $4.97, compared to a current price of $3.15 — trading 36.7% below its estimated fair value. The current Beta is 0.2107. JCR Pharmaceuticals Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current Beta is 0.2107 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of $3.15 is trading 36.7% below its estimated GF Value™ of $4.97. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for JCRRF:

  • Beta: 0.2107
  • GF Value™: $4.97 vs. price of $3.15 (36.7% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JCR Pharmaceuticals Co Business Description

Other Exchanges 4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
65GF Score

Get the complete analysis for JCRRF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.15
Price
$4.97
GF Value